trial

Studies of Frontal Lobe Brain Functioning in Schizophrenia

NCTId NCT00001258

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

Phase — · Completed

Enrollment 1,039 (actual)

Sponsored by National Institute of Mental Health (NIMH)

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Completed

Enrollment

1,039 (actual)

Study type

Observational

Allocation

—

Model

—

Masking

—

Start

1993-11-26

Primary completion

—

Eligibility

ALL · 18 Years · 90 Years

Interventions & indications

Drugs

Oxygen-15 Water

Indications

Psychotic Disorders Cognitive Dysfunction Schizophrenia Schizophrenia Parkinson Disease Parkinson Disease Healthy Subjects

Investigators

Karen F Berman, M.D.Principal Investigator

Sites

1 total

Bethesda, United States

Facts & assertions

3 sourced

Enrollment

1,039

Phase

Status

COMPLETED

relationships

The graph out of here

drug

Oxygen-15 Water

drug

lead_sponsor

National Institute of Mental Health (NIMH)

company

indication

Psychotic Disorders

indication

Cognitive Dysfunction

indication

Schizophrenia

indication

investigator

Karen F Berman, M.D.

person